22 . 02 . 2014

Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth

Xeltis completes enrollment in world’s first study of spontaneous tissue growth technology; early follow-up shows promise in children with congenial heart defect. Read more (DUTCH) (FRENCH) (GERMAN)

Go back